InterpretOmics
InterpretOmics is a Bangalore-based biotechnology company founded in 2009 that offers its iOMICS next-generation sequencing platform alongside ELISA kits, infectious disease PCR diagnostics (TB/NTM, SARS-CoV-2), and veterinary allergy tests for research labs, clinical diagnostics, and biotechnology customers.
- Company typePrivate
- Founded2009
- HeadquartersBangalore, India
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What InterpretOmics does
InterpretOmics is a Bangalore, India-based private biotechnology company founded in 2009 that operates a portfolio of life sciences products centered on next-generation sequencing (NGS) and molecular diagnostics. The company's core platform, iOMICS, is built on Illumina NGS technology and is positioned to serve genomic analysis applications in human health, bio-agriculture, and bio-energy. Surrounding the platform, InterpretOmics offers a catalog of consumable products including ELISA kits for protein detection, the PaxView TB/NTM MPCR-ULFA multiplex PCR kit for tuberculosis differential diagnosis, the ANITIA Canine IgE blood-based allergy test for veterinary use, the HiiScript II U+ one-step qRT-PCR probe kit, and ZENA SARS-CoV-2 and COVID-19 N-Antigen diagnostic kits targeting infectious disease and pandemic testing markets.
Its business model appears to combine direct product sales of branded diagnostic and research reagents with an informational/web presence that publishes scientific blog content linking to third-party laboratory equipment. The website functions in part as a content aggregator covering molecular biology and NGS topics, and the company does not disclose pricing, customer logos, revenue, or distribution partnerships in its public materials. InterpretOmics has raised at least $1.6 million in a 2013 round led by Amarante Shipping, and operates with a headcount of 11-50 employees. There is no disclosed ownership, board, or institutional investor structure beyond that single funding event, and the company is led by founder and CEO Prahalad H. Achutharao.
The company's commercial posture is that of a small, vertically integrated life sciences vendor serving research laboratories, clinical diagnostic labs, biotechnology companies, and (in the veterinary segment) companion-animal practice applications. No named customer references, channel partnerships, M&A activity, regulatory filings, or geographic expansion announcements are present in the input data, and the absence of post-2022 content signals raises questions about the company's current commercial momentum.
InterpretOmics firmographics
Firmographics- Name
- InterpretOmics
- Legal name
- Interpretomics
- Website
- https://interpretomics.co
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- InterpretOmics is a Bangalore-based biotechnology company founded in 2009 that offers its iOMICS next-generation sequencing platform alongside ELISA kits, infectious disease PCR diagnostics (TB/NTM, SARS-CoV-2), and veterinary allergy tests for research labs, clinical diagnostics, and biotechnology customers.
- Ownership category
- akta.pro rank
InterpretOmics industry classification
Industry- Product category
- Genomics & Molecular Diagnostics Software
- NAICS
- Medical Laboratories (621511)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Molecular Diagnostics (PCR/NAAT/NGS-based IVD) (HLAHAAAD)
Keywords
Where InterpretOmics is headquartered
LocationHeadquarters
- HQ city
- Bangalore
- HQ country
- India
- HQ region
- Asia
Markets served
InterpretOmics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain
Marketing channels1 record
InterpretOmics product offering
Product offeringCore offering
InterpretOmics provides a cloud-based software system (iOMICS) that enables genomics interpretation for human health, bio-agriculture, and bio-energy applications on the Illumina NGS platform. Alongside the software, it sells a portfolio of molecular diagnostic and research kits — including ELISA kits, qRT-PCR probe kits, SARS-CoV-2 N-antigen and direct RT-PCR detection kits, a multiplex TB/NTM PCR kit, and a canine IgE allergy test — to research and clinical laboratory customers.
Product overview
InterpretOmics is a biotechnology company offering a portfolio of life sciences products centered around its iOMICS next-generation sequencing platform. The product lineup includes ELISA kits for protein detection, molecular diagnostic products for infectious diseases (COVID-19, TB/NTM), veterinary allergy testing (Canine IgE), and PCR/qPCR reagent kits. The company operates in the precision diagnostics and genomics research space, providing both platform technologies and consumable products for clinical and research applications.
Differentiator
Problem solved
Functional benefit
Products and services
- iOMICS NGS/Illumina Platform Next-generation sequencing services and solutions utilizing Illumina platform technology for genomic analysis and research applications, delivered as InterpretOmics' core cloud-based genomics software platform.
- ELISA Kits Enzyme-linked immunosorbent assay kits for detection and quantification of proteins, antibodies, or antigens in various biological samples, supplied to research and clinical laboratory customers.
- COVID-19 N-Antigen Detection Product SARS-CoV-2 nucleocapsid protein antigen detection product for COVID-19 diagnosis using chemiluminescent immunoassay technology, intended for clinical diagnostic laboratories.
- PaxView TB/NTM MPCR-ULFA Kit Multiplex PCR kit for detection and differentiation of Mycobacterium tuberculosis (TB) and non-tuberculous mycobacteria (NTM) infections, for clinical and reference laboratories.
- ANITIA Canine IgE Allergy Test Blood-based allergy testing kit for detection of allergen-specific IgE antibodies in dogs, enabling identification of environmental and food allergens for veterinary diagnostic use.
- HiiScript II U+ One Step qRT-PCR Probe Kit One-step quantitative reverse transcription PCR probe kit with heat-labile UDG anti-contamination system for sensitive detection of RNA targets, used in research and molecular biology workflows.
- ZENA SARS-CoV-2 Direct Detection Kit Real-time reverse transcriptase PCR (RT-PCR) kit for direct detection of SARS-CoV-2 viral RNA from clinical samples including nasopharyngeal swabs, intended for clinical diagnostic use.
Companies that use InterpretOmics
Customer profileSegments1 record
Ideal customer profiles1 record
InterpretOmics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
InterpretOmics partnerships and signals
Strategic signalRecent moves5 records
Expansion highlights3 records
InterpretOmics competitors and assessment
Company assessmentBroad incumbents
- Illumina: Dominant global NGS platform and instrument provider that also offers bioinformatics software (BaseSpace, DRAGEN) — comparable to InterpretOmics on the iOMICS/Illumina platform positioning, though at vastly larger scale and broader scope.
- BGI Group: Global genomics and molecular diagnostics conglomerate with NGS services, PCR reagents, and COVID-19 testing products — a broad incumbent comparable to InterpretOmics across both the sequencing services and infectious disease diagnostics verticals.
- QIAGEN: Global molecular diagnostics and sample-preparation technologies company with PCR kits, IVD assays, and bioinformatics (QIAGEN Digital Insights) — overlapping with InterpretOmics's TB/NTM PCR kits, COVID-19 detection, and bioinformatics offerings.
- Thermo Fisher Scientific: Global life sciences tools leader spanning PCR/qPCR instruments and reagents (Applied Biosystems), NGS, and clinical diagnostics — overlapping with InterpretOmics's qRT-PCR reagent kits and broader molecular diagnostics portfolio.
Direct peers
- Strand Life Sciences: Bangalore-based genomics informatics and molecular diagnostics company combining bioinformatics software with clinical lab services — directly comparable to InterpretOmics on the dual software-plus-diagnostics model, geographic base, and target customer set in India.
- DNAnexus: Cloud-based bioinformatics platform for NGS data management and clinical genomics — directly comparable to InterpretOmics's iOMICS cloud software offering, with similar SaaS-based delivery and life sciences customer base.
- MedGenome: India-headquartered genomics and molecular diagnostics company offering NGS-based genetic testing, hereditary disease diagnostics, and oncology panels. Comparable to InterpretOmics in NGS service delivery and Indian clinical diagnostics focus.
Emerging players
- Xcode Life: India-based personal genomics and bioinformatics company providing DNA-based health and trait reports — a smaller, more consumer-focused peer overlapping with InterpretOmics on genomics interpretation software for the Indian market.
- Mapmygenome: Indian personal genomics and preventive health company offering DNA-based health, wellness, and ancestry tests — overlapping with InterpretOmics on the genomics software/analysis layer and Indian customer base, though more consumer-oriented.
- Seven Bridges (now Velsera): Cloud-based bioinformatics platform supporting multi-omics data analysis and clinical genomics workflows — comparable to InterpretOmics's iOMICS platform in NGS interpretation and tertiary analysis use cases.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat2 records
Key risks6 records
Key highlights5 records
Customer concentration
InterpretOmics social profiles
Digital presenceInterpretOmics financial estimates
Financial estimateRevenue estimate
Valuation estimate
InterpretOmics leadership team
Management profileNumber of profiles
Profiles1 record
InterpretOmics funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
InterpretOmics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about InterpretOmics
What does InterpretOmics do?
InterpretOmics provides a cloud-based software system (iOMICS) that enables genomics interpretation for human health, bio-agriculture, and bio-energy applications on the Illumina NGS platform. Alongside the software, it sells a portfolio of molecular diagnostic and research kits — including ELISA kits, qRT-PCR probe kits, SARS-CoV-2 N-antigen and direct RT-PCR detection kits, a multiplex TB/NTM PCR kit, and a canine IgE allergy test — to research and clinical laboratory customers.
Is InterpretOmics a public or private company?
InterpretOmics is a private company. It is classified as venture growth investor backed and is currently operating.
When was InterpretOmics founded?
InterpretOmics was founded in 2009. It employs 11 to 50 people.
Where is InterpretOmics based?
InterpretOmics is headquartered in Bangalore, India, in the Asia region.
Who are InterpretOmics's main competitors?
Broad incumbents on record are Illumina, BGI Group, QIAGEN and Thermo Fisher Scientific. Direct peers are Strand Life Sciences, DNAnexus and MedGenome. Emerging players are Xcode Life, Mapmygenome and Seven Bridges (now Velsera).
Does InterpretOmics have an API?
No public API is recorded for InterpretOmics.
What industry is InterpretOmics in?
InterpretOmics's product category is Genomics & Molecular Diagnostics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGADAF, Molecular & Genetic Testing (PCR/NGS/qPCR). Its NAICS code is 621511 and its SIC code is 2835.